Cherry Tree Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.73M Sell
1,497
-21
-1% -$24.8K 0.33% 66
2026
Q2
$1.82M Hold
1,518
– – 0.34% 59
2026
Q1
$1.4M Buy
1,518
+2
+0.1% +$2.03K 0.3% 64
2025
Q4
$1.63M Sell
1,516
-11
-0.7% -$10.5K 0.34% 59
2025
Q3
$1.17M Hold
1,527
– – 0.26% 65
2025
Q2
$1.19M Sell
1,527
-13
-0.8% -$10.1K 0.28% 64
2025
Q1
$1.27M Buy
1,540
+9
+0.6% +$7.49K 0.31% 61
2024
Q4
$1.18M Hold
1,531
– – 0.29% 61
2024
Q3
$1.36M Hold
1,531
– – 0.32% 59
2024
Q2
$1.39M Buy
1,531
+10
+0.7% +$8K 0.35% 58
2024
Q1
$1.18M Hold
1,521
– – 0.3% 60
2023
Q4
$887K Sell
1,521
-32
-2% -$18.7K 0.24% 69
2023
Q3
$834K Hold
1,553
– – 0.24% 62
2023
Q2
$728K Buy
+1,553
New +$651K 0.21% 65

Other funds holding LLY

Cherry Tree Wealth Management's LLY Position: Q3 2026 in Review

Cherry Tree Wealth Management reduced its Eli Lilly (LLY) stake by 1.4% in Q3 2026, selling an estimated $24.8K and leaving 1,497 shares worth $1.73M. The position accounts for 0.33% of the portfolio, ranked #66.

Cherry Tree Wealth Management first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.82M in Q2 2026. 1,552 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cherry Tree Wealth Management held 1,497 shares of Eli Lilly worth $1.73M as of Q3 2026.
  • Cherry Tree Wealth Management sold 21 Eli Lilly shares in Q3 2026, an estimated $24.8K.
  • Eli Lilly made up 0.33% of Cherry Tree Wealth Management's portfolio in Q3 2026, its #66 holding.
  • Cherry Tree Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
  • Cherry Tree Wealth Management's Eli Lilly position peaked at $1.82M in Q2 2026.
  • 1,552 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.